Significance of proliferating cell nuclear antigen (PCNA) expression in gastric cancer in relation to lymph node metastasis

J Surg Oncol. 1996 Feb;61(2):106-10. doi: 10.1002/(SICI)1096-9098(199602)61:2<106::AID-JSO4>3.0.CO;2-G.

Abstract

Proliferating cell nuclear antigen (PCNA) in gastric cancer was evaluated in relation to lymph node metastasis. A total of 125 gastric cancer patients who underwent gastrectomy were studied immunohistochemically. The PCNA-positive rate of the primary lesion with lymph node metastasis (47.6%) was significantly higher than those in those without metastasis (24.3%, P < 0.0001). The PCNA-positive rate of early gastric cancer was significantly higher in lesions with lymph node metastasis (36.9%) than in lesions without lymph node metastasis (14.7%). However, there was no significant difference between lesions with and without lymph node metastasis in advanced gastric cancer. In addition, the PCNA-positive rate in metastatic lesions (44.6%) was significantly higher than that in the primary lesion (40.0%, P = 0.001). It is concluded that gastric cancer with higher tumor growth activity has a higher rate of lymph node metastasis. Cancer cells in the metastatic foci of lymph node have a higher proliferating activity than that in the primary lesion.

MeSH terms

  • Female
  • Humans
  • Immunohistochemistry
  • Lymph Nodes / immunology
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Proliferating Cell Nuclear Antigen / analysis*
  • Stomach Neoplasms / immunology*
  • Stomach Neoplasms / pathology*

Substances

  • Proliferating Cell Nuclear Antigen